# Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

> **NCT04474405** · EARLY_PHASE1 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 36 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Flortaucipir F18
- **PROCEDURE:** Brain PET Scan
- **PROCEDURE:** Whole body PET scan
- **DRUG:** Florbetapir F 18
- **PROCEDURE:** Brain MRI

## Key facts

- **NCT ID:** NCT04474405
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-16
- **Primary completion:** 2013-12-09
- **Final completion:** 2013-12-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04474405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04474405, "Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04474405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*